| Mrs Keesha Leigh Kuntz, LPC #4250 | |
|
417 E Silas St, Bartlesville, OK 74003 | |
| (918) 337-6050 | |
| (918) 337-6061 |
| Full Name | Mrs Keesha Leigh Kuntz |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 417 E Silas St, Bartlesville, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013153824 | NPI | - | NPPES |
| 200316290A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Secondary |
| 101YP2500X | Counselor - Professional | LPC#4250 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Keesha Leigh Kuntz, LPC #4250 417 E Silas St, Bartlesville, OK 74003 Ph: (918) 337-6050 | Mrs Keesha Leigh Kuntz, LPC #4250 417 E Silas St, Bartlesville, OK 74003 Ph: (918) 337-6050 |
News Archive
Like people in cities, microbes often live in complex communities that contain many different microbial types. Also like us, microbes tend to gravitate to and "hang out" with certain other types in their community, more than with the rest. And sometimes, when opportunities arise, they move to more favorable locations.
The Institute for Health Technology Studies (InHealth) has awarded three new research grants totaling more than $1.4 million to investigators at the University of Southern California, Northwestern University, and Stanford University. The funding will support three separate studies that will examine the social and economic impact of therapeutic medical devices, as well as the device innovation process.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that at approximately $120 million, the hepatitis C virus drug market in Brazil is among the largest emerging pharmaceutical markets for the disease.
Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for the treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Ohio State University researchers have evidence that blood samples can reliably detect fibromyalgia, a disease that is often misdiagnosed due to its general symptoms that characterize a number of other conditions.
› Verified 6 days ago
Jimmie Charles Chase, BS,CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 622 Se Frank Phillips Blvd, Bartlesville, OK 74003 Phone: 918-336-4646 Fax: 918-336-8710 | |
Mrs. Kimber Joanna Kinsey, Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 S Penn Ave, Bartlesville, OK 74003 Phone: 918-440-6454 | |
Paula Manley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 S Penn Ave, Bartlesville, OK 74003 Phone: 918-337-8080 Fax: 378-337-8099 | |
Kristin Nicole Neal, Counselor Medicare: Medicare Enrolled Practice Location: 2200 Se Washington Blvd, Bartlesville, OK 74006 Phone: 918-335-1111 Fax: 918-335-1119 | |
Julie Jeannette Brown, M.S., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 S Penn Ave, Bartlesville, OK 74003 Phone: 918-337-8080 Fax: 918-337-8099 | |
Katherine Ann Wilson, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 700 Sw Penn, Bartlesville, OK 74003 Phone: 918-402-0811 |